Project Details
Projekt Print View

Mechanism of extracellular citrate uptake and metabolism in cancer; specificity and potential use of gluconate in cancer therapy

Subject Area General and Visceral Surgery
Term from 2018 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 411622433
 
Final Report Year 2022

Final Report Abstract

We were able to successfully complete work on five out of six work packages. One work package (Aim 2) proved to not be possible, but led nevertheless to new insights into the intriguing regulation mechanism of citrate transporter expression. During the project we designed experiments on the gluconate inhibition, which allowed us to overcome the problems experienced in Aim 2. Based on the results of all 6 work packages, we can summarize our findings as follows: 1. Citrate is an important metabolite in tumour progression, which we found is synthesized and released by cancer-associated stroma. 2. Import of extracellular citrate significantly increases flexibility of cancer metabolism and the increased amount of citrate enables cancer cells to efficiently use different biochemical pathways. 3. Gluconate exhibits a high specificity for pmCiC expressed in cancer cells and did not produce any effects on the benign cells including those expressing pmCiC, but with the function of citrate release. 4. pmCiC is expressed in most cancer cells and cancer-associated stroma of all the human tumour types studied until now. It is not present at significant levels in the benign cells we have tested.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung